Purchases and Sales Made in Q4 2023 in Vertex Pharmaceuticals Inc (VRTX)
This table provides information about the institutional ownership of Vertex Pharmaceuticals Inc (VRTX) during Q4 2023. The information is specifically focused on institutions that hold shares of VERTEX PHARMACEUTICALS INC .
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2024
Q4 2023
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-133K- 4.73% |
$45.6M - $54.6M
|
2.68M
$1.35B
|
|
|
Feb 05, 2024
Q4 2023
|
Victory Capital Management Inc
|
SELL
|
- |
-143K- 24.65% |
$48.9M - $58.6M
|
436K
$219M
|
|
|
Feb 14, 2024
Q4 2023
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-174K- 6.27% |
$59.6M - $71.4M
|
2.6M
$1.31B
|
|
|
Feb 08, 2024
Q4 2023
|
Robeco Institutional Asset Management B.V.
|
SELL
|
- |
-188K- 43.37% |
$64.4M - $77.1M
|
245K
$123M
|
|
|
Feb 13, 2024
Q4 2023
|
Winslow Capital Management, LLC
Minneapolis, MN |
SELL
|
- |
-194K- 17.35% |
$66.6M - $79.8M
|
925K
$465M
|
|
|
Feb 14, 2024
Q4 2023
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-200K- 53.33% |
$68.6M - $82.1M
|
175K
$87.9M
|
|
|
Feb 13, 2024
Q4 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-210K- 12.41% |
$72.2M - $86.4M
|
1.48M
$746M
|
|
|
May 16, 2024
Q4 2023
|
Bank Julius Baer & Co. Ltd, Zurich
|
SELL
|
- |
-214K- 74.93% |
$73.5M - $88M
|
71.7K
$36M
|
|
|
Feb 08, 2024
Q4 2023
|
Massachusetts Financial Services CO
Boston, MA |
SELL
|
- |
-266K- 6.83% |
$91.2M - $109M
|
3.63M
$1.82B
|
|
|
Feb 14, 2024
Q4 2023
|
Bellevue Group Ag
Kuesnacht, V8 |
SELL
|
- |
-266K- 26.56% |
$91.4M - $109M
|
736K
$370M
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-278K- 8.54% |
$95.4M - $114M
|
2.98M
$1.5B
|
|
|
Feb 14, 2024
Q4 2023
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-334K- 45.65% |
$114M - $137M
|
397K
$200M
|
|
|
Feb 09, 2024
Q4 2023
|
Clearbridge Investments, LLC
New York, NY |
SELL
|
- |
-351K- 11.91% |
$120M - $144M
|
2.59M
$1.3B
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-424K- 39.75% |
$145M - $174M
|
643K
$323M
|
|
|
Feb 14, 2024
Q4 2023
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-428K- 14.56% |
$147M - $176M
|
2.51M
$1.26B
|
|
|
Feb 14, 2024
Q4 2023
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-469K- 82.29% |
$161M - $192M
|
101K
$50.7M
|
|
|
Jan 26, 2024
Q4 2023
|
Impax Asset Management Group PLC
|
SELL
|
- |
-474K- 84.89% |
$163M - $195M
|
84.3K
$42.4M
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-482K- 7.89% |
$165M - $198M
|
5.62M
$2.83B
|
|
|
Feb 14, 2024
Q4 2023
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-487K- 6.47% |
$167M - $200M
|
7.04M
$3.54B
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-704K- 3.12% |
$241M - $289M
|
21.9M
$11B
|
|
|
Feb 14, 2024
Q4 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-963K- 14.05% |
$330M - $395M
|
5.89M
$2.96B
|